The Carlyle Group (CG) has agreed to acquire Unchained Labs for $435 million, in partnership with its management team, from Novo Holdings A/S, Canaan Partners and TPG Biotech. Headquartered in Pleasanton, CA, Unchained Labs is a life science tools company focused on solving problems for biologics and gene therapy researchers.

Create Account

Dark

chart

exchange

Check out our Level2View

The Carlyle Group (CG) has agreed to acquire Unchained Labs for $435 million, in partnership with its management team, from Novo Holdings A/S, Canaan Partners and TPG Biotech. Headquartered in Pleasanton, CA, Unchained Labs is a life science tools company focused on solving problems for biologics and gene therapy researchers.

RTTNews | Apr 26, 2021 08:14AM EDT

08:14 Monday, April 26, 2021 (RTTNews.com) - The Carlyle Group (CG) has agreed to acquire Unchained Labs for $435 million, in partnership with its management team, from Novo Holdings A/S, Canaan Partners and TPG Biotech. Headquartered in Pleasanton, CA, Unchained Labs is a life science tools company focused on solving problems for biologics and gene therapy researchers.

The company said its investment in Unchained Labs is a continuation of Carlyle's long-term global commitment to healthcare, in which it has invested more than $16 billion of equity since inception.

Read the original article on RTTNews ( https://www.rttnews.com/3188014/carlyle-group-to-acquire-unchained-labs-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved